Funding for this research was provided by:
Canadian Institutes of Health Research
Academic Health Sciences Centre (AHSC) Alternate Funding Plan (AFP) Innovation Fund
Canadian HIV Trials Network, Canadian Institutes of Health Research (CA)
Text and Data Mining valid from 2018-07-03
Received: 17 October 2017
Accepted: 25 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: Ethics approval was obtained from the St. Michael’s Hospital Research Ethics Board (REB # 16–348) and the Toronto Public Health Research Ethics Board (File #2016–16). Informed consent to participate is to be obtained from all participants.
: Not applicable.
: Malika Sharma, Arlene Chan, Sharmistha Mishra, Mark Gilbert, Daniel Grace, Rita Shahin, Isaac Bogoch, Ahmed M. Bayoumi, Tim Rogers, John Maxwell, James Wilton, Owen McEwen and Allison Chris have no competing interests to declare.Dr. David Knox has consulted for ViiV Health Sciences and received honoraria from Merck and Gilead Sciences.Dr. Tan reports grants from Canadian Institutes of Health Research & Ontario HIV Treatment Network, during the conduct of the study; grants from Gilead, grants from ViiV Healthcare, and participation in clinical trials sponsored by GSK, outside the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.